Related Experiment Video

Updated: May 1, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.1K

Spectrum of HIV antibodies in vaccine and disease

Georgia D Tomaras1, David C Montefiori

  • 1aDuke Human Vaccine Institute bDepartment of Surgery cDepartment of Immunology dDepartment of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, USA.

Current Opinion in HIV and AIDS
|March 28, 2014
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

13.8K

Related Experiment Videos

Last Updated: May 1, 2026

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.1K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.6K
Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay
07:10

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

13.8K

Related Concept Videos

Cross-reactivity00:42

Cross-reactivity

28.7K
Overview
28.7K
Vaccinations01:51

Vaccinations

44.1K
Overview
44.1K
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

3.7K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.7K
Cytomegalovirus Disease01:27

Cytomegalovirus Disease

102
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
102

Articles linked to this work by shared authors, journal, and citation graph.

A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates.

Science immunology·2021

In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.

Cell·2021

Prediction of serum HIV-1 neutralization titers of VRC01 in HIV-uninfected Antibody Mediated Prevention (AMP) trial participants.

Human vaccines & immunotherapeutics·2021

Structural and genetic convergence of HIV-1 neutralizing antibodies in vaccinated non-human primates.

PLoS pathogens·2021

Fab-dimerized glycan-reactive antibodies are a structural category of natural antibodies.

Cell·2021

A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.

Journal of virology·2021

The interaction of comorbidities, aging, and HIV persistence in tissues.

Current opinion in HIV and AIDS·2026

Weight gain, adipose tissue remodeling and cardiometabolic disease in people with HIV.

Current opinion in HIV and AIDS·2026

Weight gain in people with HIV in Africa and Asia: a review of causes, consequences, and management implications.

Current opinion in HIV and AIDS·2026

Recent insights from prophylactic passive immunization trials of HIV-1 broadly neutralizing antibodies: implications for vaccine design.

Current opinion in HIV and AIDS·2026

Population health and epidemiologic trends in weight gain among people with HIV.

Current opinion in HIV and AIDS·2026

Induction of HIV broadly neutralizing antibodies with vaccination in humans in discovery medicine trials.

Current opinion in HIV and AIDS·2026

HSV-1 induces stable associations between the Golgi and endosomes within the cytoplasmic viral assembly compartment of neuronal cells.

Journal of virology·2026

Targeting CLK1 by CRISPR tools and pharmacological inhibition modulates the innate immune response and dengue virus replication.

The Biochemical journal·2026

Changing Burden of Opportunistic Infections in the New ART Era.

Recent advances in anti-infective drug discovery·2026

Alveolar macrophage heterogeneity in pulmonary hypertension: pathogenic mechanisms and precision intervention.

Journal of hypertension·2026

Pulmonary ILC2 Priming as a Link Between Severe Early-Life RSV Bronchiolitis and Asthma.

American journal of respiratory cell and molecular biology·2026

Anemoside B4 from Pulsatilla chinensis Ameliorates Ulcerative Colitis by Inhibiting Inflammatory Responses via the Modulation of the Gut Microbiota-Immune Interplay.

The American journal of Chinese medicine·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us